S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

LEXX Lexaria Bioscience Corporation

2.64

0.02 (0.76%)

Jul 03 2024 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience (NASDAQ:LEXX)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Lexaria Bioscience Charts.

Lexaria Bioscience Corporation News

Form DEF 14A - Other definitive proxy statements
Wednesday 6 March 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 March 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 16 February 2024 (5 months ago) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Friday 16 February 2024 (5 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Wednesday 14 February 2024 (5 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 30 January 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 24 January 2024 (5 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Wednesday 24 January 2024 (5 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 18 January 2024 (6 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 12 January 2024 (6 months ago) • Edgar (US Regulatory)

Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
Thursday 11 January 2024 (6 months ago) • GlobeNewswire Inc.

More Lexaria Bioscience Corporation News Articles

Vontobel Financial Produ...

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions